ValenzaBio partners ProBioGen to maximize cell line productivity in Europe
Biologics | News | 0 Comment | 09 Aug, 2021
ProBioGen and ValenzaBio jointly initiate a cell line development project involving the application of ProBioG...Read more
Bioreactor sales upsurge with ramped-up COVID-19 vaccine production
Biologics | Opinion | 2 Comment | 25 May, 2021
Bioreactor technology has evolved over time and is still expanding as its requirements in biopharmaceutical and biotechn...Read more
BeiGene receives manufacturing approval for biologics facility in China
Biologics | News | 0 Comment | 08 Apr, 2021
BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines w...Read more
Abu Dhabi based ADQ invests Rs 555 crore in Biocon Biologics
Biologics | News | 0 Comment | 08 Jan, 2021
Biocon Ltd, an innovation-led global biopharmaceuticals company based in India, announced that the Board of its subsidia...Read more
Celltrion to invest $520M for new plant in China
Biologics | News | 0 Comment | 24 Jan, 2020
South Korea's Celltrion Inc. said it will spend 600 billion won (US$520 million) on its new plant in China over the next...Read more
Singapore to host 7th Annual Biologics Manufacturing Asia 2020
Biologics | News | 0 Comment | 28 Oct, 2019
The biologics industry in Asia- Pacific is estimated to be the fastest-growing market in the world. For instance, Asia- ...Read more
Biocon Biologics expands R&D footprint
Biologics | News | 0 Comment | 24 Sep, 2019
Asia’s premier biopharmaceuticals company, has announced that its subsidiary, Biocon Biologics, has acquired R&...Read more
I-Mab gets IND approval for TJC4 antibody
Biologics | News | 0 Comment | 15 Jul, 2019
I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovat...Read more
Potential treatment strategies for human cancer uncovered in bats
Biologics | News | 1 Comment | 02 Jul, 2019
Researchers from Duke-NUS Medical School, Singapore have uncovered a potential mechanism behind cancer suppression in ba...Read more
NMPA accepts NDA for biosimilar product candidate of Rituximab
Biologics | News | 0 Comment | 27 Jun, 2019
Innovent Biologics and Eli Lilly and Company have jointly announced that the National Medical Products Administration (N...Read more
Biocon Biologics receive EU GMP Certification
Biologics | News | 0 Comment | 14 Jun, 2019
Biocon has received the Certificate of GMP compliance from EMA for its Biologics Drug Product (DP) as well as Drug Subst...Read more
NTU team explore binding secrets of superglue protein
Biologics | News | 0 Comment | 06 Jun, 2019
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have pinpointed how a special class of plant...Read more
Alphamab completes $60 M Series B Financing
Biologics | News | 0 Comment | 29 May, 2019
Alphamab Oncology, a leading biopharmaceutical company based in China dedicated to global development of innovative biol...Read more
Signalling protein may unleash the potential of drug-based therapies to treat hyperparathyroidism
Biologics | News | 0 Comment | 28 May, 2019
Researchers at Duke-NUS Medical School, Singapore have discovered “Sema3d”, a signalling protein that appear...Read more
EMA accepts Prestige Biopharma's MAA for review
Biologics | News | 0 Comment | 28 May, 2019
Prestige BioPharma has announced that European Medicines Agency (EMA) has validated and accepted for review the Mar...Read more
Translational research led by Singapore scientists uncovers new treatment for fatty liver disease
Biologics | News | 0 Comment | 24 May, 2019
A team of researchers at Singapore that deactivating a specific protein − interleukin 11 (IL11) – with drugs...Read more
WuXi Biologics commences construction of center for Innovative Biologics
Biologics | News | 0 Comment | 17 May, 2019
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions fo...Read more
Takeda's BLA for Vedolizumab gets approval by U.S. FDA
Biologics | News | 0 Comment | 14 May, 2019
Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for rev...Read more